BioPharmSignal logoBioPharmSignal

Biotech News

Clover Health to Participate in Upcoming Investor Conferences

Clover Health (CLOV)Clover HealthCompany update

WILMINGTON, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences: Interim Chief Financial Officer, Clay Thornton, will present at the 2026

Related news

CLOVClover Health2026-07-22 20:05 EST

Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference

CLOVClover Health2026-02-17 21:05 EST

Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference

View all latest news

Clover Health

Medicare Advantage Clover Health operates a wide-network Medicare Advantage plan designed to improve access and outcomes for older adults, including populations that have historically lacked affordable, high-quality care. Clover Assistant Its clinical model is powered by Clover Assistant, an AI-enabled software platform that aggregates...

Recent company news

CLOVClover Health2026-08-31 20:05 EST

Clover Health to Participate in Upcoming Investor Conferences

CLOVClover Health2026-08-05 20:05 EST

Clover Health Reports Second Quarter 2026 Results

CLOVClover Health2026-07-22 20:05 EST

Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference

CLOVClover Health2026-07-09 20:05 EST

Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026

CLOVClover Health2026-07-07 12:30 EST

Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up

Stock data

Close
4.54 USD
Market cap
1.96B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States